BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10744389)

  • 1. Acute priapism associated with the use of sildenafil in a patient with sickle cell trait.
    Kassim AA; Fabry ME; Nagel RL
    Blood; 2000 Mar; 95(5):1878-9. PubMed ID: 10744389
    [No Abstract]   [Full Text] [Related]  

  • 2. Sildenafil citrate-associated priapism.
    Sur RL; Kane CJ
    Urology; 2000 Jun; 55(6):950. PubMed ID: 10840123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistaxis after sildenafil.
    Bott SR; Shergill I; Arya M
    J R Soc Med; 2002 Oct; 95(10):528. PubMed ID: 12356992
    [No Abstract]   [Full Text] [Related]  

  • 4. Tachyphylaxis and phosphodiesterase type 5 inhibitors.
    Steers WD
    J Urol; 2002 Jul; 168(1):207. PubMed ID: 12050542
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of type-5 phosphodiesterase: promising therapy for pulmonary hypertension.
    Watanabe H
    Intern Med; 2004 Oct; 43(10):891-3. PubMed ID: 15575233
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.
    Manganiello V
    Mol Pharmacol; 2003 Jun; 63(6):1209-11. PubMed ID: 12761329
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclic GMP phosphodiesterase-5: target of sildenafil.
    Corbin JD; Francis SH
    J Biol Chem; 1999 May; 274(20):13729-32. PubMed ID: 10318772
    [No Abstract]   [Full Text] [Related]  

  • 8. Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress.
    Bivalacqua TJ; Musicki B; Hsu LL; Berkowitz DE; Champion HC; Burnett AL
    PLoS One; 2013; 8(7):e68028. PubMed ID: 23844149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds.
    Turko IV; Ballard SA; Francis SH; Corbin JD
    Mol Pharmacol; 1999 Jul; 56(1):124-30. PubMed ID: 10385692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxation effect of nitric oxide-donor on diabetic penile smooth muscle in vitro.
    Taher A; Birowo P; Kamil ST; Shahab N
    Clin Hemorheol Microcirc; 2000; 23(2-4):277-81. PubMed ID: 11321451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism.
    Lin G; Xin ZC; Lue TF; Lin CS
    J Urol; 2003 Aug; 170(2 Pt 2):S15-8; discussion S19. PubMed ID: 12853767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle.
    Park K; Moreland RB; Goldstein I; Atala A; Traish A
    Biochem Biophys Res Commun; 1998 Aug; 249(3):612-7. PubMed ID: 9731184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors.
    Wang Y; Chackalamannil S; Hu Z; Boyle CD; Lankin CM; Xia Y; Xu R; Asberom T; Pissarnitski D; Stamford AW; Greenlee WJ; Skell J; Kurowski S; Vemulapalli S; Palamanda J; Chintala M; Wu P; Myers J; Wang P
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3149-52. PubMed ID: 12372521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ-10258859.
    Qiu Y; Bhattacharjee S; Kraft P; John TM; Craig E; Haynes-Johnson D; Guan J; Jiang W; Macielag M; Sui Z; Clancy J; Lundeen S
    Eur J Pharmacol; 2003 Jul; 472(1-2):73-80. PubMed ID: 12860475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of erectile dysfunction. Hard facts support sildenafil].
    MMW Fortschr Med; 2003 Sep; 145(35-36):50-1. PubMed ID: 14584211
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Long-term efficacy of sildenafil and tachyphylaxis effect.
    Carson CC
    J Urol; 2002 Jul; 168(1):205. PubMed ID: 12073960
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis of erectile dysfunction--what is still needed today?].
    Weiske WH
    Urologe A; 2003 Oct; 42(10):1317-21. PubMed ID: 14569379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction.
    Mason RG
    J R Soc Promot Health; 2003 Jun; 123(2):79-80. PubMed ID: 12852189
    [No Abstract]   [Full Text] [Related]  

  • 19. Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum.
    Qiu Y; Kraft P; Lombardi E; Clancy J
    J Urol; 2000 Sep; 164(3 Pt 1):882-6. PubMed ID: 10953172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil can increase the response to inhaled nitric oxide.
    Bigatello LM; Hess D; Dennehy KC; Medoff BD; Hurford WE
    Anesthesiology; 2000 Jun; 92(6):1827-9. PubMed ID: 10839936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.